-+ 0.00%
-+ 0.00%
-+ 0.00%

COGNITION THERAPEUTICS COMPLETES TYPE C MEETING WITH FDA FOR ZERVIMESINE (CT1812) IN DEMENTIA WITH LEWY BODIES

Reuters·01/27/2026 12:30:00

Please log in to view news